SQZ Biotech's Series C Round

SQZ Biotech raised a round of funding on December 05, 2017. Investors include JDRF T1D Fund.

SQZ Biotech is developing its CellSqueeze platform for use in drug discovery and clinical applications. SQZ's technology seeks to overcome longstanding barriers in the field by facilitating more effec…

Articles about SQZ Biotech's Series C Round: